Long Pentraxin PTX 3 and Faecal Calprotectin as a Non Invasive Biomarkers for Ulcerative Colitis
Open Access
- 10 February 2017
- journal article
- Published by Peertechz Publications Private Limited in Archives of Clinical Gastroenterology
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Liver Complications in Inflammatory Bowel DiseasesDigestive Diseases, 2013
- Long Pentraxin 3: Experimental and Clinical Relevance in Cardiovascular DiseasesMediators of Inflammation, 2013
- Long pentraxin 3 (PTX3) expression and release by neutrophils in vitro and in ulcerative colitisPathology International, 2011
- Pentraxins: Multifunctional proteins at the interface of innate immunity and inflammationBioFactors, 2009
- Clinical value of fecal calprotectin in determining disease activity of ulcerative colitisWorld Journal of Gastroenterology, 2008
- Increased Expression of Long Pentraxin PTX3 in Inflammatory Bowel DiseasesDigestive Diseases and Sciences, 2007
- Plasma Pentraxin 3 in Patients with Chronic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2007
- The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular trapsThe Journal of Experimental Medicine, 2007
- Establishment of a High Sensitivity Plasma Assay for Human Pentraxin3 as a Marker for Unstable Angina PectorisArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Clinical patterns, natural history, and progression of ulcerative colitisDigestive Diseases and Sciences, 1993